2025-522287-32-00招募中1 期
A randomised, double-blind, placebo-controlled phase Ib trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple doses of ACD856 in healthy participants
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 40
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Märta Segerdahl
Scientific
AlzeCure Pharma AB
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
1 期
A study to investigate if use of FOL-005 can increase hair growth.EUCTR2017-003809-17-DEFollicum AB60
已完成
不适用
Assessing the clinical benefit of food supplement, Genecol®, in subjects with joint pain at the lower, upper limbs or at the lumbar spineJoint painMusculoskeletal DiseasesOther joint disorders, not elsewhere classifiedISRCTN76960238utraveris (France)200
已完成
不适用
A double-blind, randomised, placebo-controlled phase III study of the efficacy of a bivalent Pseudomonas aeruginosa flagella vaccine in patients with cystic fibrosisNutritional, Metabolic, EndocrineCystic fibrosisISRCTN98785888The Society for the fight of Cystic Fibrosis (The Gesellschaft zur Bekämpfung der Mukoviszidose e.V.) (Germany)483
进行中（未招募）
1 期
A randomised, double-blind, placebo-controlled Phase IIIb Study investigating changes in immunological parameters and cutaneous reactivity induced by a short course immunotherapy with ALK grass tablets.EUCTR2006-005263-26-ESALK-Abelló, S.A.
进行中（未招募）
1 期
A randomised, double-blind, placebo-controlled Phase II study, comparing the efficacy and safety of inhaled SNG001 to placebo administered to asthmatic subjects after the onset of a respiratory viral infection for the prevention or attenuation of asthma symptoms caused by respiratory virusesEUCTR2009-017480-42-GBSynairgen Research Ltd147